IRIS Accounts Production v23.3.0.418 11806226 director 1.3.22 28.2.23 28.2.23 false true false false true false Ordinary £1 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118062262022-02-28118062262023-02-28118062262022-03-012023-02-28118062262021-02-28118062262021-03-012022-02-28118062262022-02-2811806226ns10:Originalns15:EnglandWales2022-03-012023-02-2811806226ns14:PoundSterlingns10:Original2022-03-012023-02-2811806226ns10:Originalns10:Director12022-03-012023-02-2811806226ns10:Original2022-03-012023-02-2811806226ns10:Original2023-02-2811806226ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2811806226ns10:Originalns10:SmallEntities2022-03-012023-02-2811806226ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2811806226ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2811806226ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2811806226ns10:Originalns10:FullAccounts2022-03-012023-02-2811806226ns10:Originalns10:OrdinaryShareClass12022-03-012023-02-2811806226ns10:Originalns10:RegisteredOffice2022-03-012023-02-2811806226ns10:Original2022-02-2811806226ns10:Originalns5:CurrentFinancialInstruments2023-02-2811806226ns10:Originalns5:CurrentFinancialInstruments2022-02-2811806226ns10:Originalns5:Non-currentFinancialInstruments2023-02-2811806226ns10:Originalns5:Non-currentFinancialInstruments2022-02-2811806226ns5:ShareCapitalns10:Original2023-02-2811806226ns5:ShareCapitalns10:Original2022-02-2811806226ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2811806226ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2811806226ns10:Originalns5:PlantMachinery2022-03-012023-02-2811806226ns10:Original2021-03-012022-02-2811806226ns10:Originalns5:PlantMachinery2022-02-2811806226ns10:Originalns5:PlantMachinery2023-02-2811806226ns10:Originalns5:PlantMachinery2022-02-2811806226ns10:Originalns5:AdditionsToInvestments2023-02-2811806226ns10:Originalns5:CostValuation2023-02-2811806226ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2811806226ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-02-2811806226ns10:Originalns10:OrdinaryShareClass12023-02-28
REGISTERED NUMBER: 11806226 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2023

FOR

NOTTINGHAM GYNAECOLOGY LTD

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NOTTINGHAM GYNAECOLOGY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2023







Director: D Nunns





Registered office: 10 Stadium Business Court
Millennium Way
Pride Park
Derby
Derbyshire
DE24 8HP





Registered number: 11806226 (England and Wales)





Accountants: Haines Watts (East Midlands) Ltd
10 Stadium Business Court
Millennium Way
Pride Park
Derby
Derbyshire
DE24 8HP

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

BALANCE SHEET
28 FEBRUARY 2023

2023 2022
Notes £ £
Fixed assets
Tangible assets 4 45,217 58,878
Investments 5 20,600 -
65,817 58,878

Current assets
Debtors 6 128,062 18,661
Cash at bank 118,642 139,579
246,704 158,240
Creditors
Amounts falling due within one year 7 (46,163 ) (16,351 )
Net current assets 200,541 141,889
Total assets less current liabilities 266,358 200,767

Creditors
Amounts falling due after more than one
year

8

(43,549

)

(50,335

)
Net assets 222,809 150,432

Capital and reserves
Called up share capital 10 100 100
Retained earnings 222,709 150,332
Shareholders' funds 222,809 150,432

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 November 2023 and were signed by:





D Nunns - Director


NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

1. STATUTORY INFORMATION

Nottingham Gynaecology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
Cost
At 1 March 2022 79,478
Additions 1,411
At 28 February 2023 80,889
Depreciation
At 1 March 2022 20,600
Charge for year 15,072
At 28 February 2023 35,672
Net book value
At 28 February 2023 45,217
At 28 February 2022 58,878

5. FIXED ASSET INVESTMENTS
Other
investments
£
Cost
Additions 20,600
At 28 February 2023 20,600
Net book value
At 28 February 2023 20,600

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Trade debtors 36,976 18,497
Other debtors 91,086 164
128,062 18,661

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Hire purchase contracts 6,786 6,786
Taxation and social security 37,522 6,650
Other creditors 1,855 2,915
46,163 16,351

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£ £
Hire purchase contracts 43,549 50,335

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2023

9. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£ £
Hire purchase contracts 50,335 57,121

Amounts owed under Hire Purchase contracts are secured against the asset to which they relate.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £ £
100 Ordinary £1 £1 100 100

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2023 and 28 February 2022:

2023 2022
£ £
**UNKNOWN DIRECTOR 1**
Balance outstanding at start of year (122 ) -
Amounts advanced 90,000 -
Amounts repaid (650 ) (122 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 89,228 (122 )

The overdrawn Director Loan Account was cleared in full after the year end, but before the date of these Reports.